Submission Details
| 510(k) Number | K843122 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 08, 1984 |
| Decision Date | November 30, 1984 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
K843122 is an FDA 510(k) clearance for the RESOLVE-CSF, a Total Spinal-fluid, Antigen, Antiserum, Control (Class I — General Controls, product code DFI), submitted by Isolab, Inc. (Akron, US). The FDA issued a Cleared decision on November 30, 1984, 114 days after receiving the submission on August 8, 1984. This device falls under the Chemistry review panel. Regulated under 21 CFR 866.5860.
| 510(k) Number | K843122 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 08, 1984 |
| Decision Date | November 30, 1984 |
| Days to Decision | 114 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | — |
| Product Code | DFI — Total Spinal-fluid, Antigen, Antiserum, Control |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.5860 |